Stock market today: Stocks fall as investors rotate out of tech into Jackson Hole
Elisha W. Finney, a director at ICU Medical Inc. (NASDAQ:ICUI), a medical technology company with a market capitalization of $3.4 billion, recently sold 600 shares of the company’s common stock. According to InvestingPro data, while ICU Medical isn’t currently profitable, analysts expect positive earnings in 2025. The transaction, which took place on May 19, 2025, was executed at a price of $138.92 per share, totaling $83,352. Following this sale, Finney holds 3,252 shares of ICU Medical. The shares were sold at the exact price disclosed, as noted in the filing. InvestingPro analysis indicates the stock is currently slightly undervalued, with analysts setting price targets between $175 and $200. Get access to detailed financial metrics and 6 additional ProTips with an InvestingPro subscription.
In other recent news, ICU Medical reported impressive financial results for the first quarter of 2025, with earnings and revenue figures exceeding analysts’ expectations. The company announced an adjusted earnings per share (EPS) of $1.72, surpassing the forecasted $1.27, and reported revenue of $599 million, above the anticipated $567.08 million. ICU Medical also experienced a 10% revenue growth in constant currency terms, driven by strong performance in its Consumables and Infusion Systems segments. Despite the positive earnings report, Needham maintained a Hold rating on ICU Medical’s stock, citing the company’s current valuation as a factor. The firm’s recent joint venture with Otsuka Pharmaceutical (TADAWUL:2070) Factory for IV Solutions was completed on May 1, 2025, with expectations to mitigate tariff impacts partially through favorable currency exchange rates and internal strategies. Additionally, ICU Medical expanded its stock incentive plan, increasing the number of shares available for issuance to align the interests of employees and directors with shareholders. The company continues to focus on growth and profitability while navigating challenges such as tariff impacts and currency fluctuations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.